» Articles » PMID: 16172260

A Role for TSLP in the Development of Inflammation in an Asthma Model

Overview
Journal J Exp Med
Date 2005 Sep 21
PMID 16172260
Citations 240
Authors
Affiliations
Soon will be listed here.
Abstract

Thymic stromal lymphopoietin (TSLP) is a cytokine that promotes CD4+ T cell homeostasis. We now demonstrate that TSLP is required to mount a normal CD4+ T cell-mediated inflammatory response. TSLP acts directly on naive, but not, memory CD4+ T cells, and promotes their proliferation in response to antigen. In addition, TSLP exerts an effect indirectly through DCs to promote Th2 differentiation of CD4+ T cells. Correspondingly, TSLP receptor (TSLPR) knockout (KO) mice exhibit strong Th1 responses, with high levels of interleukin (IL)-12, interferon-gamma, and immunoglobulin (Ig) G2a, but low production of IL-4, -5, -10, -13, and IgE; moreover, CD4+ T cells from these animals proliferate less well in response to antigen. Furthermore, TSLPR KO mice fail to develop an inflammatory lung response to inhaled antigen unless supplemented with wild-type CD4+ T cells. This underscores an important role for this cytokine in the development of inflammatory and/or allergic responses in vivo.

Citing Articles

Tissue-Resident Th2 Cells in Type 2 Immunity and Allergic Diseases.

Mannion J, Rahimi R Immunol Rev. 2025; 330(1):e70006.

PMID: 39981858 PMC: 11897987. DOI: 10.1111/imr.70006.


A sensitive red/far-red photoswitch for controllable gene therapy in mouse models of metabolic diseases.

Qiao L, Niu L, Wang M, Wang Z, Kong D, Yu G Nat Commun. 2024; 15(1):10310.

PMID: 39604418 PMC: 11603164. DOI: 10.1038/s41467-024-54781-2.


IL-7-dependent and -independent lineages of IL-7R-dependent human T cells.

Arango-Franco C, Ogishi M, Unger S, Delmonte O, Orrego J, Yatim A J Clin Invest. 2024; 134(19).

PMID: 39352394 PMC: 11444196. DOI: 10.1172/JCI180251.


Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma.

Palacionyte J, Januskevicius A, Vasyle E, Rimkunas A, Miliauskas S, Malakauskas K Diagnostics (Basel). 2024; 14(13).

PMID: 39001236 PMC: 11240777. DOI: 10.3390/diagnostics14131345.


IL-4 acts on skin-derived dendritic cells to promote the T2 response to cutaneous sensitization and the development of allergic skin inflammation.

Leyva-Castillo J, Das M, Strakosha M, McGurk A, Artru E, Kam C J Allergy Clin Immunol. 2024; 154(6):1462-1471.e3.

PMID: 38996877 PMC: 11625010. DOI: 10.1016/j.jaci.2024.06.021.


References
1.
Levin S, Koelling R, Friend S, Isaksen D, Ziegler S, Perlmutter R . Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. J Immunol. 1999; 162(2):677-83. View

2.
Grunig G, Warnock M, Wakil A, Venkayya R, Brombacher F, Rennick D . Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998; 282(5397):2261-3. PMC: 3897229. DOI: 10.1126/science.282.5397.2261. View

3.
Kaech S, Tan J, Wherry E, Konieczny B, Surh C, Ahmed R . Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol. 2003; 4(12):1191-8. DOI: 10.1038/ni1009. View

4.
Watanabe N, Hanabuchi S, Soumelis V, Yuan W, Ho S, De Waal Malefyt R . Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion. Nat Immunol. 2004; 5(4):426-34. DOI: 10.1038/ni1048. View

5.
Pulendran B . Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors. Immunol Res. 2004; 29(1-3):187-96. DOI: 10.1385/IR:29:1-3:187. View